EX-23.1 6 a2233667zex-23_1.htm EX-23.1

Exhibit 23.1

 

CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM

 

We consent to the incorporation by reference in this Registration Statement on Form S-3 of our report dated March 6, 2017, relating to the financial statements of Ra Pharmaceuticals, Inc. appearing in the Annual Report on Form 10-K of Ra Pharmaceuticals, Inc. for the year ended December 31, 2016, and to the reference to us under the heading “Experts” in the Prospectus, which is part of this Registration Statement.

 

/s/ Deloitte & Touche LLP

 

 

 

Boston, Massachusetts

 

November 1, 2017

 

 

49